Recombinant trivalent polio vaccine(（Sf-RVN cells)

重组三价脊髓灰质炎疫苗（Sf-RVN细胞）

Report date: 2025/07/16 18:01:01

Base Information

Drug NameRecombinant trivalent polio vaccine(（Sf-RVN cells)

Drug Alias NamePolio vaccine candidate based on virus-like particle(Cansino)VLP-IPVCS-2036

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustraliaMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesTianjin Cansino Biotechnology Inc

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesTianjin Cansino Biotechnology Inc

Inactive CompaniesN/A

Active IndicationsPoliomyelitis

Inactive IndicationsN/A

Other Information

ATC CodeN/A